Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

Share Price is delayed by 15 minutes
Get Live Data
16.50    0.00 (0.00%)
Bid:
16.00
Ask:
17.00
Spread: 1.00 (6.25%)
Market Cap: £18.10m
TEAM Live PriceLast checked at - London Stock Exchange

Intraday Team Share Chart

Form 8 Opening Position Disclosure

21 Nov 2025 17:00

RNS Number : 6081I
Team PLC
21 November 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TEAM PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TEAM PLC

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

 20 November 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

YES

 

If yes, specify which

 

WH IRELAND GROUP PLC

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary of No Par Value

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

NONE

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by the directors of TEAM PLC, their close relatives and related trusts

 

Name of Director

Number of TEAM PLC ordinary shares held

Percentage of issued share capital (excluding treasury shares) (%)*

MARK CLUBB

4,787,939

7.70

PHILIP TAYLOR

258,645

0.41

 

*Figures shown to two decimal places (unrounded)

 

(b) Interests held as options or award under the share plans of TEAM PLC by the directors of TEAM PLC and their close relatives and related trusts who are not exempt principal traders for the purposes of Rule 8 of the Code

 

N/A

 

(c) Interests and short positions held by connected advisors of TEAM PLC

 

N/A

 

(d) Interests of any other persons acting in concert with the Offeror

 

N/A

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

20 November 2025

Contact name:

Iain Walker

Telephone number:

01534 888804

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEPKDBQABDDCDB
Date   Source Headline
9th Dec 20252:20 pmRNSForm 8.3 Team PLC
9th Dec 202512:08 pmRNSForm 8.3 - TEAM PLC
9th Dec 202511:00 amRNSLoan Note Extension
5th Dec 202510:01 amRNSForm 8.3 - Team PLC
4th Dec 20255:45 pmRNSForm 8.3 - TEAM PLC
4th Dec 20254:49 pmRNSForm 8.3 - TEAM Plc
4th Dec 202511:42 amGNWForm 8.5 (EPT/RI) - Team Plc
1st Dec 202510:40 amGNWForm 8.5 (EPT/RI) - Team Plc
28th Nov 20252:45 pmRNSForm 8.3 - Team PLC
28th Nov 20252:20 pmRNSForm 8.3 - Team plc
28th Nov 202510:13 amGNWForm 8.5 (EPT/RI) - Team Plc
27th Nov 20255:20 pmRNSHolding(s) in Company
27th Nov 202511:52 amGNWForm 8.5 (EPT/RI) - Team Plc
27th Nov 20257:30 amRNSRECOMMENDED ACQUISITION OF W.H. IRELAND GROUP PLC
27th Nov 20257:26 amRNSForm 8.3 - TEAM Plc
26th Nov 20257:04 amRNSForm 8.3 - Team plc
21st Nov 20255:00 pmRNSForm 8 Opening Position Disclosure
21st Nov 20253:45 pmRNSHolding(s) in Company
21st Nov 202511:50 amGNWForm 8.5 (EPT/RI) - Team Plc
17th Nov 202510:28 amGNWForm 8.5 (EPT/RI) - Team Plc
14th Nov 20253:13 pmRNSForm 8.3 - Team Plc
14th Nov 202511:26 amGNWForm 8.5 (EPT/RI) - Team Plc
14th Nov 20259:26 amGNWForm 8.3 - [TEAM PLC - Opening Disclosure - 13 11 2025] - (CGAML)
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:59 amRNSReplacement- Statement regarding media speculation
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20258:15 amRNSStatement regarding recent media speculation
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
8th Sep 20256:00 pmRNSHolding(s) in Company
3rd Sep 20253:42 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNS-RDirectorsTalk Interview
6th Aug 20257:00 amRNSLaunch of UCITS Fund
16th Jul 20252:35 pmRNSChange of Registered Office Address
30th Jun 20257:06 amRNSHalf-year Report
19th Jun 202512:45 pmRNSHolding(s) in Company
25th Apr 20256:16 pmRNSHolding(s) in Company
25th Apr 20257:00 amRNSResult of AGM
8th Apr 20252:24 pmRNSEquity Subscription
7th Apr 20254:11 pmRNSHolding(s) in Company
3rd Apr 202512:30 pmRNSUpdated Notice of AGM
27th Mar 20256:28 pmRNSDirector’s Dealing
27th Mar 20252:47 pmRNSDirector/PDMR Shareholding
25th Mar 20254:30 pmRNSDirector/PDMR Shareholding
24th Mar 20254:40 pmRNSDirector's Dealing - Replacement
24th Mar 202511:21 amRNSDirector's Dealing
21st Mar 20252:15 pmRNSEquity Subscription
20th Mar 20257:00 amRNSProposed Board Changes and Notice of AGM
4th Mar 20258:15 amRNSDirector/PDMR Shareholding
3rd Mar 20257:10 amRNSFund Raise and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.